» Articles » PMID: 34184256

Addressing Patient Heterogeneity in Disease Predictive Model Development

Overview
Journal Biometrics
Specialty Public Health
Date 2021 Jun 29
PMID 34184256
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

This paper addresses patient heterogeneity associated with prediction problems in biomedical applications. We propose a systematic hypothesis testing approach to determine the existence of patient subgroup structure and the number of subgroups in patient population if subgroups exist. A mixture of generalized linear models is considered to model the relationship between the disease outcome and patient characteristics and clinical factors, including targeted biomarker profiles. We construct a test statistic based on expectation maximization (EM) algorithm and derive its asymptotic distribution under the null hypothesis. An important computational advantage of the test is that the involved parameter estimates under the complex alternative hypothesis can be obtained through a small number of EM iterations, rather than optimizing the objective function. We demonstrate the finite sample performance of the proposed test in terms of type-I error rate and power, using extensive simulation studies. The applicability of the proposed method is illustrated through an application to a multicenter prostate cancer study.

Citing Articles

Comparing the performance of statistical, machine learning, and deep learning algorithms to predict time-to-event: A simulation study for conversion to mild cognitive impairment.

Billichova M, Coan L, Czanner S, Kovacova M, Sharifian F, Czanner G PLoS One. 2024; 19(1):e0297190.

PMID: 38252622 PMC: 10802955. DOI: 10.1371/journal.pone.0297190.

References
1.
Lipkovich I, Dmitrienko A, Denne J, Enas G . Subgroup identification based on differential effect search--a recursive partitioning method for establishing response to treatment in patient subpopulations. Stat Med. 2011; 30(21):2601-21. DOI: 10.1002/sim.4289. View

2.
Cai T, Tian L, Wong P, Wei L . Analysis of randomized comparative clinical trial data for personalized treatment selections. Biostatistics. 2010; 12(2):270-82. PMC: 3062150. DOI: 10.1093/biostatistics/kxq060. View

3.
Berger J, Wang X, Shen L . A Bayesian approach to subgroup identification. J Biopharm Stat. 2014; 24(1):110-29. DOI: 10.1080/10543406.2013.856026. View

4.
Fan A, Song R, Lu W . Change-Plane Analysis for Subgroup Detection and Sample Size Calculation. J Am Stat Assoc. 2017; 112(518):769-778. PMC: 5553128. DOI: 10.1080/01621459.2016.1166115. View

5.
Jones H, Ohlssen D, Neuenschwander B, Racine A, Branson M . Bayesian models for subgroup analysis in clinical trials. Clin Trials. 2011; 8(2):129-43. DOI: 10.1177/1740774510396933. View